CIK 0001661059 · Non-accelerated filer<br>Smaller reporting company
NextCure, Inc.
Sign in to watch- Ticker
- NXTC
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 475231247
- Phone
- 240-399-4900
- Business address
- 2850 QUARRY LAKE DRIVE, SUITE 280, BALTIMORE, MD, 21209
- Open-market buys, last 90 days
- $77,590
- in 2 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$77,590. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-06-24 | Xu Stella Director | Grant or award · Stock Option (Right to Buy) | +14,250 | 14,250 | ||
| 2021-06-24 | KABAKOFF DAVID S Director | Grant or award · Stock Option (Right to Buy) | +14,250 | 14,250 | ||
| 2021-06-24 | Jones Elaine V Director | Grant or award · Stock Option (Right to Buy) | +14,250 | 14,250 | ||
| 2021-06-24 | Webster Stephen W Director | Grant or award · Stock Option (Right to Buy) | +14,250 | 14,250 | ||
| 2021-06-24 | Khuong Chau Quang Director | Grant or award · Stock Option (Right to Buy) | +14,250 | 14,250 | ||
| 2021-03-15 | Richman Michael President & CEO | Grant or award · Employee Stock Option (Right to Buy) | +300,000 | 300,000 | ||
| 2021-03-15 | Mayer Timothy Chief Operating Officer | Grant or award · Employee Stock Option (Right to Buy) | +100,000 | 100,000 | ||
| 2021-03-15 | Liu Linda SVP, Research | Grant or award · Employee Stock Option (Right to Buy) | +100,000 | 100,000 | ||
| 2021-03-15 | Langermann Sol Chief Scientific Officer | Grant or award · Employee Stock Option (Right to Buy) | +100,000 | 100,000 | ||
| 2021-03-15 | Cobourn Steven P. Chief Financial Officer | Grant or award · Employee Stock Option (Right to Buy) | +100,000 | 100,000 | ||
| 2021-01-13 | Myint Han Chief Medical Officer | Grant or award · Employee Stock Option (Right to Buy) | +200,000 | 200,000 | ||
| 2020-09-10 | Houston John G Director | Grant or award · Stock Option (Right to Buy) | +28,500 | 28,500 | ||
| 2020-09-10 | Houston John G Director | Grant or award · Stock Option (Right to Buy) | +10,687 | 10,687 | ||
| 2020-07-14 | Heller Kevin N. Chief Medical Officer | Option exercise | +27,229 | $1.77 | $48K | 49,011 |
| 2020-07-14 | Heller Kevin N. Chief Medical Officer | Option exercise · Employee Stock Option (Right to Buy) | −27,229 | 38,119 | ||
| 2020-06-11 | Xu Stella Director | Grant or award · Stock Option (Right to Buy) | +14,250 | 14,250 | ||
| 2020-06-11 | Webster Stephen W Director | Grant or award · Stock Option (Right to Buy) | +14,250 | 14,250 | ||
| 2020-06-11 | Morrison Briggs Director | Grant or award · Stock Option (Right to Buy) | +14,250 | 14,250 | ||
| 2020-06-11 | Li Judith Director | Grant or award · Stock Option (Right to Buy) | +14,250 | 14,250 | ||
| 2020-06-11 | Khuong Chau Quang Director | Grant or award · Stock Option (Right to Buy) | +14,250 | 14,250 |
Page 6 of 10 · 197 trades